Almirall, S.A. (ALMRY)

OTCMKTS · Delayed Price · Currency is USD
10.76
+0.90 (9.08%)
At close: Apr 24, 2025
15.89%
Market Cap 2.40B
Revenue (ttm) 1.11B
Net Income (ttm) 26.32M
Shares Out n/a
EPS (ttm) 0.12
PE Ratio 91.24
Forward PE 31.16
Dividend 0.12 (1.12%)
Ex-Dividend Date Jun 3, 2024
Volume 100
Average Volume 185
Open 10.76
Previous Close 9.86
Day's Range 10.76 - 10.76
52-Week Range 9.40 - 10.76
Beta 0.39
RSI 64.41
Earnings Date May 12, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 2,026
Stock Exchange OTCMKTS
Ticker Symbol ALMRY
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.